Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:          
Net income (loss) $ 369,100 $ (134,319) $ 765,044   $ 146,617
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     31,893   31,412
Loss (gains) on unrealized foreign exchange and other     4,790   (883)
Stock-based compensation expense     31,833   27,770
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:          
Accounts receivable     (19,790) $ (22,202) (169,498)
Inventories     (70,847)   (44,434)
Other assets     18,125   82,290
Accounts payable     (17,205)   2,192
Deferred system revenue     (99,533)   0
Deferred service revenue     (1,114)   0
Deferred system profit     0   69,179
Other liabilities     20,381   358,355
Net cash provided by operating activities     663,577   503,000
Cash flows from investing activities:          
Acquisition of non-marketable securities     0   (3,377)
Business acquisitions, net of cash acquired     (11,787)   (5,490)
Capital expenditures     (48,696)   (29,125)
Purchases of available-for-sale securities     (2,686)   (326,012)
Proceeds from sale of available-for-sale securities     198,608   106,601
Proceeds from maturity of available-for-sale securities     382,809   391,760
Purchases of trading securities     (32,100)   (30,790)
Proceeds from sale of trading securities     37,334   35,382
Net cash provided by investing activities     523,482   138,949
Cash flows from financing activities:          
Proceeds from revolving credit facility, net of debt issuance costs     0   248,693
Repayment of debt     0   (696,250)
Issuance of common stock     20,556   20,579
Tax withholding payments related to vested and released restricted stock units     (30,194)   (26,195)
Common stock repurchases     (550,187)   (80,354)
Payment of dividends to stockholders     (237,319)   (192,902)
Net cash used in financing activities     (797,144)   (726,429)
Effect of exchange rate changes on cash and cash equivalents     (315)   4,823
Net increase (decrease) in cash and cash equivalents     389,600   (79,657)
Cash and cash equivalents at beginning of period     1,404,382   1,153,051
Cash and cash equivalents at end of period 1,793,982 1,073,394 1,793,982 1,793,982 1,073,394
Supplemental cash flow disclosures:          
Income taxes paid     112,816   147,483
Interest paid     51,673   58,698
Non-cash activities:          
Business acquisition holdback amounts - investing activities     440   0
Contingent consideration payable - financing activities     2,529   0
Accrued purchases of land, property and equipment - investing activities     7,705   5,548
Unsettled common stock repurchase - financing activities     0   1,289
Dividends payable - financing activities $ 5,404 $ 7,590 $ 5,404 $ 5,404 $ 7,590